AI in Community Medicine / PSM / Public Health
In Indian public health, AI is used most in TB screening from chest X-rays and in scanning news for disease outbreaks. Much else, such as predicting disease risk from community data, is still at study stage. Residents should know both the uses and the limits: bias, poor data and privacy.
What AI does in Community Medicine / PSM / Public Health
Software reads X-rays in community camps and marks people who need a confirmatory test. A 2025 study reported higher TB case yield in active case finding.
Examples: qXR (Qure.ai), CAD4TB, Lunit INSIGHT CXR
A tool scans digital news across India for infectious disease reports and alerts district officers. It has run since April 2022 and issued over 4,500 alerts per press coverage.
Examples: Media Disease Surveillance tool (Government of India)
A tool that screens for pulmonary TB in community settings. Government information reported 12-16% extra case yield compared with usual screening.
Examples: Cough Against TB
Chat tools draft health education material in local languages. Staff must review for accuracy.
Examples: General chat assistants
Models use case counts, weather and mobility data to predict dengue, malaria or COVID waves.
Examples: Not listed
Models estimate diabetes or kidney disease risk from simple community data to decide who gets screened first.
Examples: Not listed
routine = in everyday use in many centres · early adoption = in use at some sites, evidence still building · research = studies only
Key ideas for this specialty
New to the basics? Start with the theory lessons.
Tools
Chest X-ray AI with TB screening and active case finding use. The vendor page shows CE and FDA marks and does not show CDSCO.
Regulatory status: CE marked and FDA cleared per vendor page; CDSCO not shown on page
Android app and online portal to report adverse drug reactions to the Indian Pharmacopoeia Commission; relevant to public health drug safety.
Regulatory status: Not listed
Finds and summarises papers for your dissertation literature review. Free tier available.
Regulatory status: Not listed
Official TB data and guidance, including reports from 1997 to 2025.
Regulatory status: Not listed
A listing here is not an endorsement. Ask any vendor for its CDSCO licence and class before clinical use.
Where to learn
The Indian rulebook for any AI study or programme you plan.
Policy-level view of risks and recommendations for governments and providers.
Indian-journal overview of AI in surveillance, prediction and communication.
No-code introduction; the evaluation course helps you judge AI tools for programmes.
A real field study of AI X-ray screening in community case finding.
Free Indian AI basics for non-programmers; not health-specific.
Do it yourself
Read the TB AI-CAD field study and list its population, reference test, threshold and yield. Write a half-page on whether it would work in your district.
Open the dataset or tool →Use the WHO TB page and the reviewed papers to note the sensitivity and specificity targets for CAD. Compute how many false positives a camp of 1000 people would get at your local TB prevalence.
Open the dataset or tool →Use public or properly de-identified data only, and get ethics approval before any project on your own patients.
Papers worth reading
- AI-CAD enhances pulmonary TB detection and yield in active case finding IJTLD Open, 2025
- Role of Artificial Intelligence in Public Health RGUHS National Journal of Public Health, 2024
Societies and guidance
AI ethical guidelines for biomedical research and healthcare.
AI ethics and governance guidance.
Recent updates
National Health Authority review meeting puts AI and digital health in the next phase of PM-JAY and ABDM
A two-day review (17 to 18 July) of Ayushman Bharat PM-JAY and ABDM set AI, digital services and claims financing as priorities. It also covered linking medical college hospital information systems to ABDM standards and an NMC dashboard for college assessment.
Source: Indian Pharma PostNature Medicine: LLM decision support in Kenyan clinics improved care quality but not short-term outcomes
A cluster-randomised trial of an LLM tool ('AI Consult') inside the record system, in 16 primary care clinics with over 9,600 patients, improved documentation and treatment planning. Treatment failure was 2.2% with the tool and 2.0% without, and no harm signal was seen.
Source: University of BirminghamIndiaAI and ICMR sign MoU on health AI
The agreement brings IndiaAI's compute and dataset platforms together with ICMR's research expertise, using ICMR's MIDAS framework for responsible AI in health.
Source: All India Radio (News on AIR)Chhattisgarh study: AI chest X-ray screening for TB raised case notifications by 80%
In Open Forum Infectious Diseases, qXR reading of 2,745 X-rays in a tribal population flagged 363 presumptive cases, 162 were confirmed, and notifications rose 80.21% against baseline. It also found 51 asymptomatic people who symptom screening would have missed.
Source: Open Forum Infectious Diseases (PMC)India notifies the DPDP Rules 2025; core duties apply from May 2027
Consent manager rules apply from 13 November 2026, and most duties for data fiduciaries apply 18 months after notification, on 13 May 2027. The rules require reasonable security safeguards and set no separate health-specific category.
Source: S.S. Rana & Co.Links checked 3 October 2026. “Not listed” means we could not confirm the detail, not that it is absent. Educational material, not clinical advice.